Sounds really dangerous:<p><a href="https:&#x2F;&#x2F;wikileaks.org&#x2F;tpp-ip3&#x2F;pharmaceutical&#x2F;Pharmaceutical%20Provisions%20in%20the%20TPP.pdf" rel="nofollow">https:&#x2F;&#x2F;wikileaks.org&#x2F;tpp-ip3&#x2F;pharmaceutical&#x2F;Pharmaceutical%...</a><p>&quot;Marketing exclusivity for new forms and uses of old medicines could be considered a form of evergreening. Since marketing exclusivity applies regardless of the patent status of a drug, even off-patent medicines presented in the forms and uses described below would not have a generic competitor.&quot;